Interdepartmental Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Siena, Italy.
Autoimmun Rev. 2012 Nov;12(1):10-3. doi: 10.1016/j.autrev.2012.07.015. Epub 2012 Aug 2.
Hereditary periodic fever syndromes (HPFSs) are a group of inherited disorders of the innate immune system caused by mutations of genes involved in the regulation or activation of the inflammatory response, which belong to the category of autoinflammatory disorders. Most HPFs typically have an onset in pediatric age, while a limited number of patients experience disease onset during adulthood. The relative rarity and lack of information on adult-onset autoinflammatory diseases make it likely that genetic testing is often inconclusive. Recently, we have identified a set of variables related to the probability of detecting gene mutations in MEFV, responsible for familial Mediterranean fever, and TNFRSF1A, responsible for tumor necrosis factor receptor-associated periodic syndrome. In addition, we have proposed a diagnostic score for identifying those patients at high risk of carrying mutations in these genes. However, before the score can be recommended for application, further evaluation by means of longitudinal studies on different ethnicities and different populations deriving from other geographical areas is needed in order to definitively verify both its sensitivity and its specificity. The present manuscript offers our suggestions on how to establish a differential diagnosis for adult-onset HPFs, as well as a review of the literature, and we also provide a score revision available online.
遗传性周期性发热综合征(HPFSs)是一组由参与炎症反应调节或激活的基因发生突变引起的固有免疫系统遗传疾病,属于自身炎症性疾病范畴。大多数 HPFS 通常在儿童时期发病,而少数患者在成年期发病。由于成人发病的自身炎症性疾病相对罕见,且信息有限,因此基因检测通常结果不确定。最近,我们已经确定了一组与家族性地中海热的 MEFV 基因和肿瘤坏死因子受体相关周期性综合征的 TNFRSF1A 基因中基因突变检测概率相关的变量。此外,我们还提出了一种诊断评分,用于确定这些基因携带突变的高风险患者。然而,在推荐该评分用于临床应用之前,需要通过对不同种族和来自其他地理区域的不同人群进行纵向研究来进一步评估,以明确验证其敏感性和特异性。本文档提供了关于如何为成人发病的 HPFS 建立鉴别诊断的建议,以及对文献的回顾,同时还提供了在线可用的评分修订版本。